Alpha Tau Medical Ltd. (DRTS)
NASDAQ: DRTS · Real-Time Price · USD
15.03
+0.41 (2.80%)
At close: Sep 4, 2026, 4:00 PM EDT
15.09
+0.06 (0.37%)
After-hours: Sep 4, 2026, 7:49 PM EDT
Alpha Tau Medical Market Cap
Alpha Tau Medical has a market cap or net worth of $1.39 billion as of September 4, 2026. Its market cap has increased by 362.28% in one year.
Market Cap
1.39B
Enterprise Value
1.30B
1-Year Change
362.28%
Ranking
Category
Stock Price
$15.03
ChartMarket Cap Chart
Since March 8, 2021, Alpha Tau Medical's market cap has increased from $347.19M to $1.39B, an increase of 299.72%. That is a compound annual growth rate of 28.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.39B | 228.81% |
| Dec 31, 2025 | 422.06M | 94.21% |
| Dec 31, 2024 | 217.32M | 3.92% |
| Dec 29, 2023 | 209.12M | -4.71% |
| Dec 30, 2022 | 219.46M | -34.99% |
| Dec 31, 2021 | 337.56M | -2.77% |
| Mar 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 1.45B |
| Alumis | 1.44B |
| Cullinan Therapeutics | 1.42B |
| Replimune Group | 1.42B |
| Alto Neuroscience | 1.40B |
| Odyssey Therapeutics | 1.38B |
| Omeros | 1.37B |
| Savara | 1.36B |